Status of Erythrocyte Sedimentation Rate, Platelet Counts and Serum Phosphate in Patients with Rheumatoid Arthritis in Owerri
DOI:
https://doi.org/10.64229/yh1y6w35Keywords:
Erythrocyte Sedimentation Rate, Platelet Counts, Serum Phosphate, Rheumatoid ArthritisAbstract
In this study, rheumatoid arthritis patients receiving treatment at the Imo State University Medical Centre in Owerri had their erythrocyte sedimentation rate, platelet counts, and serum phosphate levels examined. For the study, a total of sixty (60) people were chosen. At the Imo State University Medical Center in Owerri, they were divided into two groups: thirty (30) for the test group and thirty (30) for the control group. The Westergreen method was used to measure the rate of erythrocyte sedimentation. Using the "blue" ascorbic acid method, the serum phosphate was measured. Additionally, a manual method was used to count the platelets. The test individuals' erythrocyte sedimentation rate (55.85± 14.75 mm/hr) and the control group's (8.00± 2.98 mm/hr) were compared. Test individuals' platelet count (434.20±183.98x109/L) were contrasted with the control group's (179.90±23.27x109/L). The test subjects' serum phosphate (3.58±0.46 mg/dl) were contrasted with the control group's (2.71±0.62 mg/dl). The erythrocyte sedimentation rate for the male test group (44.71±10.81 mm/hr) and female test group (61.85±13.23 mm/hr) were compared. The male test group's platelet count 473.14±129.06x109/L) and female test group's (413.14±209.54x109/L) were compared. Serum phosphate levels in the male test group (3.20±0.35 mg/dl) and the female test group (3.79±0.37 mg/dl) were compared. For both male and female subjects, the test group's mean and standard deviation of erythrocyte sedimentation rate level were higher than those of the test and control groups of rheumatoid subjects, respectively, as were platelet counts and serum phosphate levels
References
[1]Eustice C, (2023). “Causes, treatments, and complications of RA Thrombocytosis and Thrombocytopenia. Medically reviewed by M. Sansone.
[2]Gasparyan A, Ayvazyan L, Mukanova U, Yessirkepov M, Kitas G. (2019). “The platelet-to-lymphocyte Ratio as an inflammatory marker in rheumatic diseases”. Annuals of Laboratory Medicine 39(4): 345-357.
[3]Conforti A., Ilenia Di Cola, Viktoriya P. and Piero R., (2021). “Beyound the joints, the extra-articular manifestations in rheumatoid arthritis”. Autoimmunity Review 20(2):102735.
[4]Harifi G, and Sibilia J, (2016). “Pathogenic role of platelets in rheumatoid arthritis and systemic autoimmune diseases”. Saudi Medical Journal 37(4): 354-360
[5]Ahmed H.M, Zaki M. Mohamed A.S, and Ahmed A.E (2023). “Some genetic differences in patients with rheumatoid arthritis”. BioMed Central research notes 16:274.
[6]Chaurasia N, Anup S, Indramani S, Tara S, and Trayambak T, (2020). “Cognitive dysfunction in patients of rheumatoid arthritis”. Journal of Family Medicine and Primary Care 9(5): 2219-2225.
[7]Feleki Y. (2022). “Clinical manifestations and Treatment pattern”. Open Access Rheumatol 14:22-229.
[8]Colquhoun M, Gulati M, Farah Z and Mouyis M, (2021). “Clinical features of rheumatoid arthritis”. Medicinejournal.co.uk 50(3):138-142.
[9]Bogale Z,and Yeweyenhareg F. (2022). “Prevalence, clinical manifestations, and Treatment pattern of patients with rheumatoid arthritis attending the Rheumatology clinic at Tikur Anbess a specialized Hospital, Ethiopia”. Open Access Rheumatol 14:221-229.
Suen HME, Pasvol G, Cunnington A.J, (2020). “Clinical and laboratory features associated with serum phosphate concentrations in malaria and other febrile illnesses”. Mala. J. 2020; 19:85.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Emeka-Obi Obioma Raluchukwu, Alfreda Chidera Onubuogu, Aloy-Amadi Oluchi C., Chinedu-madu Jane Ugochi, Okpara Lydia Tobechukwu (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
